JAIDS Journal of Acquired Immune Deficiency Syndromes:
Rate of Decay in Proportion of Condom-Protected Sex Acts Among Adolescents After Participation in an HIV Risk-Reduction Intervention
DiClemente, Ralph J. PhD*,†,‡; Brown, Jennifer L. PhD*,†; Sales, Jessica M. PhD*,†; Rose, Eve S. MSPH*
*Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA;
†Centers for AIDS Research, Department of Pediatrics, Emory University, Atlanta, GA; and
‡Division of Infectious Diseases, Epidemiology, and Immunology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.
Correspondence to: Ralph J. DiClemente, PhD, Rollins School of Public Health, Emory University, 1518 Clifton Rd, NE, Suite 554, Atlanta, GA 30322 (e-mail: firstname.lastname@example.org).
The authors have no conflicts of interest to disclose.
The authors J.L.B. was supported by K12 GM000680 from the National Institute of General Medical Sciences; and J.M.S. was supported by K01 MH085506 from the National Institute of Mental Health.
Supported by a grant from the National Institute of Mental Health (5R01 MH070537) to the first author. Additional support was provided by the Emory Center for AIDS Research (P30 AI050409), the Atlanta Clinical and Translational Science Institute (UL1TR000454), and the Center for Contextual Genetics and Prevention (P03 DA027827). Additional support for the supplement was provided by R13 MH-081733-01A1.
Received March 08, 2013
Accepted March 11, 2013
Objective: HIV risk-reduction interventions have demonstrated efficacy in enhancing the proportion of condom-protected sex (CPS) acts among diverse populations. Although postintervention exposure increase in CPS are often observed, there is scant empirical data quantifying decay of intervention efficacy (declines in CPS after cessation of the intervention among participants reporting an initial postintervention increase in CPS). Thus, the objective of this study was to quantify the rate of decay in intervention efficacy over a 24-month follow-up.
Design: African American adolescent females (ages: 14–20; n = 349) completed a baseline audio computer–assisted self-administered interview, participated in an HIV risk-reduction intervention, and were assessed at 6-month intervals for 24 months postintervention. Intervention efficacy was conceptualized as an increase in participants’ CPS relative to baseline.
Methods: Analyses focused on the subset of participants who reported an initial increase in CPS from baseline to the 6-month postintervention assessment (n = 121) to quantify the rate of decay in intervention efficacy over a 24-month follow-up period.
Results: CPS increased markedly from baseline to 6-month follow-up assessment. However, from 6 to 12 months, a marked decline in CPS was observed. Further CPS declines, though not statistically significant, were observed from 12 to 18 months and 18 to 24 months. Cumulative reductions in CPS over the entire 24-month follow-up resulted in no statistical difference between baseline and 24-month follow-up; indicative of a nonsignificant intervention effect at 24-month assessment.
Conclusions: Innovative postintervention optimization strategies are needed to minimize CPS decay over protracted time periods by reinforcing, sustaining, and potentially amplifying initial gains in condom use.
African American young women experience elevated rates of sexually transmitted diseases (STDs).1 Recent national estimates indicate that African American female adolescents between the ages of 15 and 19 experience the highest rates of chlamydia and gonorrhea.2 This is particularly alarming given that STDs pose a number of negative health consequences and increase susceptibility to HIV.3–5 African American adolescents have also been disproportionately affected by the HIV epidemic,6 accounting for 73% of adolescent HIV infections, with a diagnosis rate nearly 23 times the rate for white adolescents.7 Among African American adolescent women, the majority of incident STD/HIV infections are acquired via heterosexual transmission.7,8 Given the high prevalence of STDs and HIV among African American female adolescents, there is a clear and compelling need to develop and disseminate efficacious STD/HIV prevention interventions for this population.
Recent reviews indicate that behavioral HIV risk-reductions are efficacious in enhancing adoption of HIV-preventive sexual behaviors among adolescents, including African American females.9–18 Indeed, a number of reviews and meta-analyses indicate that risk-reduction interventions often result in increased rates of condom-protected sexual encounters, fewer sexual partners, and decreased frequency of sexual episodes.9–18 Interventions that include condom skills training, address barriers to consistent condom use, and provide strategies to improve sexual communication with sex partners are most efficacious14,15 and those that are designed to be culturally tailored and gender tailored to the target population.15 Although the cumulative findings suggest that HIV risk-reduction interventions offer protection from HIV and some STDs, they typically use a short-term follow-up period to assess programmatic efficacy. For example, in a recent meta-analysis of adolescent HIV risk-reduction interventions, the median follow-up period was 13 weeks postintervention.14 For behavior change to be meaningful, it must be durable; however, there is scant empirical data quantifying decay of intervention efficacy (declines in condom-protected sex acts after an initial postintervention increase in condom-protected sex acts) over a longer follow-up period.
Recent studies conducted with high-risk adults and adolescents have recognized the variability of initial and sustained responses to HIV/STD risk-reduction interventions (Sales JM, DiClemente RJ, Monahan JL, et al, unpublished data, 2013).19–21 These studies have demonstrated that even homogeneous subgroups show different patterns of change in response to tailored interventions (Sales JM, DiClemente RJ, Monahan JL, et al, unpublished data, 2013).20,21 For example, Sales et al22 found that 43% of African American adolescent females did not increase their condom-use behavior after participation in an evidence-based HIV prevention intervention. Those who did not change their condom-use behavior were more likely to endorse a history of physical abuse, having a current boyfriend, and elevated levels of sensation seeking.22 A second study examined patterns of sexual behaviors among adult STD clinic patients who received risk-reduction counseling and were subsequently followed for 9 months postcounseling.21 Cluster analyses identified 3 subgroups as follows: (1) sustained low-risk behaviors over time, (2) significant reduction in risk behaviors over time, and (3) increased risk behaviors over time.21 However, no baseline behaviors differentiated the 3 subgroups over time, postintervention. These studies highlight the variability in condom-use behavior subsequent to participation in an STD/HIV prevention intervention. However, there is a lack of empirical data examining the rate of condom use over longer periods of time subsequent to intervention participation among high-risk African American female adolescents.
Thus, the aim of the present study was to quantify the rate of decay in the efficacy of an evidence-based HIV prevention intervention for African American adolescent females (HORIZONS) over a 24-month follow-up period. Specifically, this study examined the durability of intervention efficacy by monitoring changes in the proportion of condom-protected sex (CPS) acts postintervention among those adolescent females reporting an increased proportion of CPS at the 6-month postintervention assessment.
From June 2005 to June 2008, African American adolescent females, ages 14–20 years, were recruited from 3 clinics providing sexual health services to predominantly inner-city adolescents in Atlanta, GA. An African American female recruiter approached adolescents in clinic waiting areas, described the study, solicited participation, and assessed eligibility. Eligibility criteria included self-identifying as African American, 14–20 years of age at time of enrollment, and reporting at least 1 episode of unprotected vaginal sex in the past 6 months. Adolescents were excluded from participation if they were married, pregnant, or attempting to become pregnant. Adolescents meeting inclusion criteria and interested in participating were scheduled to return to the clinic to complete informed consent procedures, baseline assessments, and be randomized to trial conditions. Written informed consent was obtained from all adolescents. Parental consent was waived for those younger than 18 due to the confidential nature of clinic services. Of the eligible adolescents, 94% (n = 701) enrolled in the study, completed baseline assessments, and were randomized to study conditions. Participants were compensated for travel and childcare to attend the intervention and complete assessments. The Emory University Institutional Review Board approved all study protocols.
The study was a 2-arm randomized controlled supplemental treatment trial.23 In supplemental treatment trials, participants receive a “primary” treatment and, subsequently, receive a different (supplemental) treatment to enhance effects of the primary treatment. In this study, participants randomized to the experimental condition (n = 342) received as their primary treatment a CDC evidence-based culturally appropriate and gender-appropriate HIV intervention for African American adolescent female adolescents known as HORIZONS.24 The supplemental treatment, phone-delivered HIV prevention maintenance counseling (PMC), initiated following HORIZONS, consisted of a health educator administering 9 brief tailored phone contacts approximately every 8 weeks for 18 months. Participants randomized to the comparison condition (n = 359) also received HORIZONS as their primary treatment and a placebo control; time-equivalent and dose-equivalent phone-delivered General Health Promotion supplemental treatment. The General Health Promotion condition was administered on the same schedule, 9 brief phone contacts every 8 weeks for 18 months, by a health educator.
To quantify the rate of decay in HORIZONS intervention efficacy over a 24-month follow-up period, we examined initial increases to CPS among adolescents in the comparison condition; the condition in which adolescents were “only” exposed to the HORIZONS intervention without the supplemental phone-delivered HIV PMC. Analyses in the present study focused on the subset of participants in the HORIZONS-only condition who reported an initial increase in the proportion of CPS from baseline to the 6-month postintervention assessment (n = 121).
Data collection occurred at baseline, before randomization, and at 6, 12, 18, and 24 months after participation in HORZIONS. Data collection consisted of an audio computer–assisted self-administered interview (ACASI). ACASI enhances accurate reporting, reduces social desirability bias, and minimizes reporting errors associated with low literacy.25,26 The ACASI assessed sociodemographics, sexual behaviors, and attitudes associated with HIV-preventive behaviors. Sexual behaviors were assessed at 6-month intervals post-HORIZONS intervention using strategies to facilitate recall and enhance validity of self-report (ie, Timeline Followback methodology).27,28
Participants reported their age and current educational status.
Proportion of CPS
The proportion of CPS during vaginal sex in the 6-month period before assessment was calculated by dividing the number of times condoms were used during vaginal sex by the number of times the participant reported having vaginal sex. At each assessment, participants were asked the following question: “In the past 6 months, how many times have you had vaginal sex?” After this question, participants were asked, “Of the XX times you have had vaginal sex, in the past 6 months, how many times did you use a condom?”
Analyses focused on the subset of participants who reported initial gains in the proportion of CPS from baseline to the 6-month postintervention assessment among those randomized to the comparison condition (HORIZONS only). Change in the proportion of CPS was calculated by comparing participants’ reported proportion condom use in the 6 months before baseline (before intervention participation) to their reported proportion of condom use in the 6 months before the 6-month follow-up assessment (postintervention). Proportion of CPS at the 6-month follow-up postintervention was selected because most HIV risk-reduction programs observe the largest intervention impact on behavior change (ie, increased condom use) closer to intervention participation.29 Participants in the comparison condition (HORIZONS only) who reported increases in their proportion condom use from baseline levels were included in the analyses (n = 121).
All analyses were performed using STATA version 12.0. First, descriptive statistics were calculated to examine the rate of CPS at each of the assessment time points (6-, 12-, 18-, 24-month postintervention). Second, a series of ordinary least square regression analyses were performed to examine change in the proportion of CPS between each of the assessment points (eg, difference in proportion of CPS between 12-month and 18-month postintervention assessments and between 18 and 24 months postintervention assessments).
Analyses were limited to participants in the comparison HORIOZNS only condition who reported an increased proportion of condom-protected sex acts from the baseline to 6-month postintervention assessment (n = 121). Participants were between 14- and 20-year old with mean (SD) age of 17.6 (1.7). With regard to education level at the baseline assessment, 9.9% completed the eighth grade or below, 45.5% were in high school (grades 9–12), 22.3% had graduated from high school or earned a GED, 18.2% had completed 1 or more years of college, and 4.1% described their level of education as “other.” Participants were recruited from 3 following clinical venues that provide adolescent sexual health services: a county health department STD clinic (n = 59), a hospital-based adolescent sexual health clinic (n = 17), and a planned parenthood clinic (n = 45).
Proportion of CPS
Gains in CPS reported at the 6-month assessment decayed steadily over the 24-month follow-up (Fig. 1; Table 1). The mean (standard error) of CPS was 0.39 (0.03), 0.74 (0.03), 0.60 (0.04), 0.54 (0.04), and 0.45 (0.05) at the baseline, 6-, 12-, 18-, and 24-month assessment, respectively. Differences in CPS between assessments were measured using a series of ordinary least square regression analyses (Table 2). There was an increase in CPS from baseline to 6-month follow-up assessment (t = 3.6, P < 0.001). From the 6- to 12-month assessments, the rate of CPS decreased significantly (t = −2.6, P = 0.01). Further CPS declines, though not statistically significant, were observed from the 12- to 18-month follow-up assessment and the 18- to 24-month follow-up assessment. Cumulative reductions in CPS over the entire 24-month follow-up resulted in no statistical difference between the baseline and the 24-month follow-up assessment (t = 1.4, P = 0.17), indicative of a nonsignificant intervention effect at 24-month follow-up assessment. Overall, across the entire 24-month follow-up, we observed significant monotonic decay in intervention efficacy.
Results indicate that approximately one-third of African American female adolescents increased the proportion of CPS in the first 6 months postintervention exposure. However, among those demonstrating initial increases in condom use, there was a steady, monotonic decay in the proportion of CPS over a 2-year follow-up period. The greatest decline in the proportion of CPS occurred between the 6- and 12-month postintervention follow-up assessments. Additionally, at 2 years postintervention, there was no difference in the proportion of CPS relative to baseline levels.
HORIZONS is a CDC defined evidence-based HIV prevention intervention that is culturally tailored and gender tailored for African American female adolescents.24 However, results from this study suggest that even a demonstrated evidence-based HIV/STD risk-reduction intervention may not be capable of sustaining health protective behavior changes over a protracted time period of 2 years. These findings suggest that innovative postintervention optimization strategies are needed to minimize decay in intervention effects over extended periods of time. One promising strategy is the use of phone-delivered HIV PMC. Such an approach offers a potentially cost-effective strategy to provide tailored prevention information and behavioral skills coaching to sustain HIV-preventive behaviors.30,31 Indeed, results from the parent study indicate that repeated phone-delivered health coaching sessions result in decreased sexual risk behaviors and incident STDs over extended follow-up periods (DiClemente RJ, Wingood GM, Sales JM, et al., unpublished data, 2013).
New advances in mobile technology are transforming public health.30,31 Mobile phones, unlike other technological innovations, which are often unavailable to lower socioeconomic groups, are common among adolescents; 75% own a cell phone and 38% make daily calls.32 African American adolescents, in particular, demonstrate mobile phone use that is equal to or surpasses their white peers.32,33 Thus, the increasing availability of mobile phones suggests that mobile-delivered intervention strategies that provide HIV/STD PMC can capitalize on a technology that is rapidly being adopted and integrated into African American adolescents’ lifestyle to impact HIV/STD racial disparities.34,35 Thus, the development and dissemination of efficacious and feasible prevention maintenance interventions, such as phone-delivered maintenance counseling, could be a valuable adjuvant to sustain the prevention impact of CDC evidence-based interventions and enhance the capacity of community-based agencies and health departments to reduce HIV/STD-related disparities. Currently there are no HIV/STD prevention maintenance interventions available in the “toolkit” of prevention approaches.
This study is not without limitations. First, the measure of intervention efficacy focused exclusively on the proportion of CPS. Thus, analyses may not have fully captured participants who endorsed other behavior changes (eg, reduced number of sexual partners) subsequent to participating in the intervention. However, although HORIZONS addressed a number of HIV/STD-associated behaviors, the primary target for change was condom use. Thus, many of the HORIZONS activities targeted increasing condom use. Second, the measure of intervention efficacy was collected via self-report data, which may be subject to motivational biases to underreport risk behaviors.36 Although the study employed ACASI and other enhancements to encourage accurate self-report, we cannot rule out this threat to the validity of the findings. Fourth, the data employed in this study were only from participants who returned for postintervention follow-up assessments. Thus, it is possible that adolescents who completed follow-up assessments may differ in meaningful ways from those who did return for follow-up. The findings of this study may not generalize to other young women who have participated in STD/HIV prevention programs, especially if they participated in programs that vary markedly in content from HORIZONS. Last, this study was conducted with African American female adolescents recruited from urban Southern sexual health clinics. Results may not generalize to other populations.
African American adolescent females are at increased risk for STD/HIV acquisition. To address this growing health disparity there is a need for efficacious STD/HIV prevention interventions that can sustain HIV/STD-protective health behaviors over extended periods. Although group-delivered interventions often demonstrate initial behavioral improvements after participation in the intervention, innovative cost-effective strategies to bolster intervention efficacy need to be developed, evaluated, and disseminated. Technology-delivered intervention formats offer one promising approach to reinforce and sustain HIV/STD prevention messages and HIV/STD-preventive behavior changes.
1. Datta SD, Sternberg M, Johnson RE, et al.. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med. 2007;147:89–96.
2. CDC. Chlamydia screening among sexually active young female enrollees of health plans—United States, 2000–2007. MMWR Morb Mortal Wkly Rep. 2009;58:362–365.
3. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75:3–17.
4. Stamm WE. Chlamydia trachomatis infections of the adult. In: Sexually Transmitted Diseases. Holmes KK, Sparling PF, Mardh PA, et al.. 3rd ed. New York, NY: McGraw-Hill; 1999:407–422.
5. Hook EW, Handsfield HH. Gonococcal infections in the adult. In: Holmes KK, Sparling PF, Markh PA, et al.. Sexually Transmitted Diseases. 3rd ed. New York, NY: McGraw-Hill; 1999:451–466.
6. Rangel MC, Gavin L, Reed C, et al.. Epidemiology of HIV and AIDS among adolescents and young adults in the United States. J Adolesc Health. 2006;39:156–163.
7. CDC. Diagnoses of HIV infection and AIDS among adolescents and young adults in the United States and 5 U.S. dependent areas, 2006–2009. HIV Surveill Suppl Rep. 2012;17:2–46.
8. CDC. Sexually Transmitted Disease Surveillance 2009. Atlanta, GA: U.S. Department of Health and Human Services; 2010.
9. DiClemente RJ, Crittenden CP, Rose E, et al.. Psychosocial predictors of HIV-associated sexual behaviors and the efficacy of prevention interventions in adolescents at-risk for HIV infection: what works and what doesn't work? Psychosom Med. 2008;70:598–605.
10. Chin HB, Sipe TA, Elder R, et al.. The effectiveness of group-based comprehensive risk-reduction and abstinence education interventions to prevent or reduce the risk of adolescent pregnancy, human immunodeficiency virus, and sexually transmitted infections: two systematic reviews for the guide to community preventive services. Am J Prev Med. 2012;42:272–294.
11. Pedlow CT, Carey MP. HIV sexual risk-reduction interventions for youth: a review and methodological critique of randomized controlled trials. Behav Modif. 2003;27:135–190.
12. Mullen PD, Ramirez G, Strouse D, et al.. Meta-analysis of the effects of behavioral HIV prevention interventions on the sexual risk behavior of sexually experienced adolescents in controlled studies in the United States. J Acquir Immune Defic Syndr. 2002;30:S94–S105.
13. Darbes L, Crepaz N, Lyles C, et al.. The efficacy of behavioral interventions in reducing HIV risk behaviors and incident sexually transmitted diseases in heterosexual African Americans. AIDS. 2008;22:1177–1194.
14. Johnson BT, Scott-Sheldon LAJ, Huedo-Medina TB, et al.. Interventions to reduce sexual risk for human immunodeficiency virus in adolescents: a meta-analysis of trials, 1985–2008. Arch Pediatr Adolesc Med. 2011;165:77–84.
15. Sales JM, Milhausen RR, Diclemente RJ. A decade in review: building on the experiences of past adolescent STI/HIV interventions to optimise future prevention efforts. Sex Transm Infect. 2006;82:431–436.
16. Robin L, Dittus P, Whitaker D, et al.. Behavioral interventions to reduce incidence of HIV, STD, and pregnancy among adolescents: a decade in review. J Adolesc Health. 2004;34:3–26.
17. Lyles CM, Kay LS, Crepaz N, et al.. Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000–2004. Am J Public Health. 2007;97:133–143.
18. DiClemente RJ, Milhausen R, Sales JM, et al.. A programmatic and methodologic review and synthesis of clinic-based risk-reduction interventions for sexually transmitted infections: research and practice implications. Semin Pediatr Infect Dis. 2005;16:199–218.
19. Dennis ML, Wechsberg WM, McDermeit M, et al.. The correlates and predictive validity of HIV risk groups among drug users in a community-based sample: methodological findings from a multi-site cluster analysis. Eval Program Plann. 2001;24:187–206.
20. Wechsberg WM, Dennis ML, Stevens SJ. Cluster analysis of HIV intervention outcomes among substance-abusing women. Am J Drug Alcohol Abuse. 1998;24:239–257.
21. Kalichman SC, Cain D, Knetch J, et al.. Patterns of sexual risk behavior change among sexually transmitted infection clinic patients. Arch Sex Behav. 2005;34:307–319.
22. Sales JM, Brown JL, DiClemente RJ, et al.. Exploring factors associated with non-change in condom use behavior following participation in an STI/HIV prevention intervention for African-American adolescent females. AIDS Res Treat. 2012;2012:Article ID 231417.
23. Piantadosi S. Clinical trials: A methodologic perspective. New York, NY: John Wiley & Sons, Inc.; 1997.
24. DiClemente RJ, Wingood GM, Rose ES, et al.. Efficacy of sexually transmitted disease/human immunodeficiency virus sexual risk-reduction intervention for african american adolescent females seeking sexual health services: a randomized controlled trial. Arch Pediatr Adolesc Med. 2009;163:1112–1121.
25. Turner C, Ku L, Rogers S, et al.. Adolescent sexual behavior, drug use, and violence: Increased reporting with computer survey technology. Science. 1998;280:867–871.
26. Brown JL, Vanable PA. The effects of assessment mode and privacy level on self-reports of risky sexual behaviors and substance use among young women. J Appl Soc Psychol. 2009;39:2756–2778.
27. Weinhardt L, Carey M, Maisto S, et al.. Reliability of the timeline follow-back sexual behavior interview. Ann Behav Med. 1998;20:25–30.
28. Carey MP, Carey KB, Maisto SA, et al.. Assessing sexual risk behaviour with the Timeline Followback (TLFB) approach: continued development and psychometric evaluation with psychiatric outpatients. Int J STD AIDS. 2001;12:365–375.
29. Kalichman SC, Carey MP, Johnson BT. Prevention of sexually transmitted HIV infection: a meta-analytic review of behavioral outcome literature. Ann Behav Med. 1996;18:6–15.
30. Bull A. Technology-Based Health Promotion. Thousand Oaks, CA: Sage Publications; 2011.
31. Kaiser NC, Owen JE, Winzelberg AJ. Technological advances in modifying adolescent health risk behaviors. In: DiClemente RJ, Santelli JS, Crosby RA. Adolescent Health: Understanding and Preventing Risk Behaviors. San Francisco, CA: Jossey-Bass; 2009:447–472.
34. Swendeman D, Rotheram-Borus MJ. Innovation in sexually transmitted disease and HIV prevention: internet and mobile phone delivery vehicles for global diffusion. Curr Opin Psychiatry. 2010;23:139–144.
35. Ybarra ML, Bull SS. Current trends in Internet- and cell phone-based HIV prevention and intervention programs. Current HIV/AIDS Rep. 2007;4:201–207.
36. Schroder KEE, Carey MP, Vanable PA. Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med. 2003;26:104–123.
HIV prevention interventions; condom; African American adolescents
© 2013 Lippincott Williams & Wilkins, Inc.
Highlight selected keywords in the article text.